CD163 and colorectal carcinoma: Further characterization indicated that the percentage of CD14+CD169+CD163+ cells in total circulating CD14+CD169+ monocytes from CRC patients were significantly higher than that in HC (74.27% vs. 60.14%, P<0.0001, Fig 1D).